Athira Pharma To Present Results From Phase 2/3 LIFT-AD Clinical Trial Of Fosgonimeton To Treat Alzheimer's Disease
Athira Pharma To Present Results From Phase 2/3 LIFT-AD Clinical Trial Of Fosgonimeton To Treat Alzheimer's Disease
Athira公司將發佈Fosgonimeton治療阿爾茨海默病的LIFt-AD臨床試驗2/3期結果
Athira Pharma To Present Results From Phase 2/3 LIFT-AD Clinical Trial Of Fosgonimeton To Treat Alzheimer's Disease
Athira公司將發佈Fosgonimeton治療阿爾茨海默病的LIFt-AD臨床試驗2/3期結果
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間